
Journal of Organometallic Chemistry p. 4206 - 4211 (2005)
Update date:2022-07-29
Topics:
Azad, Shamsuddin M.
Azam, Kazi A.
Kabir, Shariff E.
Saha, Madhu S.
Hossain, G.M. Golzar
Treatment of the electronically unsaturated cluster [(μ-H)Os 3(CO)8{Ph2PCH2P(Ph)C 6H4}] (1) with primary phosphines PPhH2 and PCyH2 gives the phosphido bridged compounds [(μ-H)Os 3(CO)8(μ-PPhH)(μ-dppm)] (2) and [(μ-H)Os 3(CO)8(μ-PCyH)(μ-dppm)] (3), respectively, by P-H bond activation of the phosphines and demetallation of the phenyl ring of the diphosphine ligand. Thermolysis of 2 and 3 in refluxing octane at 128 °C results in the formation of the phosphinidene compounds [(μ-H) 2Os3(CO)7(μ3-PPh)(μ-dppm)] (4) and [(μ-H)2Os3(CO)7(μ3-PCy) (μ-dppm)] (5), respectively, by further P-H bond cleavage of the phosphido groups. All the compounds have been characterized by infrared, 1H NMR, 31P{1H} NMR and mass spectroscopic data together with single-crystal X-ray diffraction studies for 4. Compound 4 consists of a triangular cluster of osmium atoms with a symmetrically capped phosphinidene ligand and a bridging dppm ligand.
Changzhou Anyi Biochem Co., Ltd.(expird)
Contact:+86-519-88836158
Address:no,51 caoda
WEIFANG RICHEM INTERNATIONAL LTD
Contact:86-536-2222176
Address:weifang,shandong
shanghai jinshan pharmaceutical Co.,Ltd
Contact:021-57363011,13681638167
Address:No. 7966 Tingfeng Road,Jinshan,Shanghai,China
Shandong Xinhua Pharmaceutical Co.,Ltd
website:http://www.xhzy.com
Contact:+86-533-2196801
Address:1 lutai road,zhangdian dis,Zibo City
Sinopharma Yibin Pharmaceutical Co.,Ltd
Contact:86-831-5109854
Address:Luolong Industry Zone
Doi:10.1016/j.tet.2005.08.015
(2005)Doi:10.1055/s-2005-918918
(2005)Doi:10.1021/jo701415m
(2007)Doi:10.1016/j.tetlet.2005.09.096
(2005)Doi:10.1002/ejoc.201300386
(2013)Doi:10.1039/jr9340000418
(1934)